BerandaLCTX • NYSEAMERICAN
add
Lineage Cell Therapeutics Inc
$0,94
Setelah Jam Perdagangan Normal:(5,85%)+0,055
$0,99
Tutup: 27 Jun, 19.56.22 GMT-4 · USD · NYSEAMERICAN · Pernyataan Penyangkalan
Tutup sebelumnya
$0,96
Rentang hari
$0,91 - $1,09
Rentang tahun
$0,37 - $1,15
Kapitalisasi pasar
214,52Â jt USD
Volume Rata-Rata
2,37Â jt
Rasio P/E
-
Hasil dividen
-
Berita pasar
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
(USD) | Mar 2025info | Perubahan Y/Y |
---|---|---|
Pendapatan | 1,50Â jt | 4,02% |
Biaya operasional | 5,03Â jt | -2,24% |
Laba bersih | -4,14Â jt | 36,73% |
Margin laba bersih | -275,57 | 39,17% |
Penghasilan per saham | -0,02 | 50,00% |
EBITDA | -6,34Â jt | 2,24% |
Tarif pajak efektif | — | — |
Neraca
Total aset
Total liabilitas
(USD) | Mar 2025info | Perubahan Y/Y |
---|---|---|
Investasi tunai jangka pdk | 47,90Â jt | 9,82% |
Total aset | 111,75Â jt | 3,01% |
Total liabilitas | 34,10Â jt | -9,06% |
Total ekuitas | 77,66 jt | — |
Saham yang beredar | 228,36 jt | — |
Harga terhadap nilai buku | 2,76 | — |
Tingkat pengembalian aset | -14,46% | — |
Tingkat pengembalian modal | -20,40% | — |
Arus Kas
Perubahan kas bersih
(USD) | Mar 2025info | Perubahan Y/Y |
---|---|---|
Laba bersih | -4,14Â jt | 36,73% |
Kas dari operasi | -4,89Â jt | 15,51% |
Kas dari investasi | 1,90Â jt | 5.107,89% |
Kas dari pembiayaan | 5,04Â jt | -64,03% |
Perubahan kas bersih | 1,99Â jt | -75,55% |
Arus kas bebas | -2,58Â jt | 21,63% |
Tentang
Lineage Cell Therapeutics, Inc. is a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs. Lineage’s programs are based on its robust proprietary cell-based therapy platform and associated in-house development and manufacturing capabilities. With this platform Lineage develops and manufactures specialized, terminally differentiated human cells from its pluripotent and progenitor cell starting materials. These differentiated cells are developed to either replace or support cells that are dysfunctional or absent due to degenerative disease or traumatic injury or administered as a means of helping the body mount an effective immune response to cancer. Wikipedia
Didirikan
1990
Situs
Karyawan
74